Viewing StudyNCT00049530



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00049530
Status: COMPLETED
Last Update Posted: 2023-06-29
First Post: 2002-11-12

Brief Title: PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Conditions & Keywords Data

Conditions:
Name
Melanoma Skin
Keywords:
Name View
stage IV melanoma View
recurrent melanoma View